SaveOurLabS.com

A proactive web site created by NILA as a source of information about competitive bidding, a potentially devastating government experiment.

National Independent Laboratory Association (NILA) is a trade association for independent laboratories that provides a forum for the sharing of technical and business expertise.


2008 Competitive Bidding History


Court Orders Temporary Halt To Competitive Bidding Demo 
4/8/08

Judge Whelan's April 4, 2008, and April 8, 2008, decisions

Late yesterday afternoon, April 8, 2008, a federal district court in San Diego ordered a temporary halt to CMS's Competitive Bidding Demonstration Project in the San Diego-Carlsbad-San Marcos communities of Southern California.

The order to temporarily halt the demonstration project resulted from a lawsuit brought by three San Diego area laboratories [Internist Laboratory, Sharp Healthcare, and Scripps Health] who had requested a preliminary injunction to prevent the project from proceeding while the legal issues are adjudicated.

In granting the plaintiff's request for a preliminary injunction, Judge Thomas J. Whelan ordered that CMS not be permitted to:

  1. Announce winning bidders [CMS had intended to announce the winning bidders on Friday, April 11];
  2. Implement or carry out the Competitive Bidding Demonstration Project for the San Diego-Carlsbad-San Marcos Metropolitan Area; and
  3. Disclose any information included in the bid applications.

Judge Whelan also ordered that the preliminary injunction remain in force "until further order of the Court," which presumably means until the Court holds a trial and issues a decision on the legal issues contained in the lawsuit.

In order to issue a preliminary injunction, certain criteria must be met, including:

  1. Establishing that the Court has jurisdiction to hear the case and that the Plaintiffs have standing to bring the lawsuit.  Both of these were affirmed in a ruling issued by Judge Whelan on Friday, April 4, 2008;  
  2. Establishing that the Plaintiff's claims are "ripe for review", i.e., ready to be heard by the Court.  For example, in denying plaintiff's February 4, 2008, request for a Temporary Restraining Order (TRO), Judge Whelan ruled that no irreparable harm had been created by requiring labs to submit bids by February 15.

On the other hand, Judge Whelan affirmed on April 4, 2008, that Plaintiffs' claims were then "ripe for review" because CMS's stated intention to announce winning bidders on April 11 presented the real possibility of irreparable harm to at least one of the Plaintiffs (Internist Laboratory);

    3. Demonstrating that the Plaintiffs:

  1. Will suffer irreparable harm;
  2.  Are likely to succeed on the merits of the case; and
  3. Will clearly suffer the balance of hardships.

Judge Whelan ruled that all of these conditions are met.  

He cited the fact that Internist Laboratory relies on Medicare for 65% of its revenue and that if Internist Laboratory fails to qualify as a winning bidder, it will undoubtedly suffer irreparable harm by being put out of business.

Judge Whelan also ruled that Plaintiffs are likely to succeed on the merits of a number of claims made in their lawsuit, including that:

  1. CMS's failure to comply with the Administrative Procedures Act (APA) was not harmless;
  2. CMS's definition of the "face-to-face" exemption from bidding is arbitrary and capricious;
  3. CMS's requiring laboratories to bid on the specimen collection fee goes beyond the agency's statutory authority and is therefore illegal.

While the Court's ruling is a very positive development, it is NOT Final!  Consider it an important, but not conclusive, steppingstone towards our ultimate goal:

Persuading Congress to Repeal the authorization for the competitive bidding demonstration project.

The Preliminary Injunction provides the laboratory community with a temporary window of time to generate additional grassroots support for the House HR 3453) and Senate (S. 2099) bills to repeal competitive bidding for Part B clinical laboratory services.

Please contact your Members of Congress and urge them to cosponsor HR 3453 and S. 2099.


Copyright
© SaveOurLabS.com